Is the Nanosonics (ASX:NAN) share price a buy?

The Nanosonics Ltd (ASX:NAN) share price has fallen heavily from its 52-week high. Is this a buying opportunity for investors?
The post Is the Nanosonics (ASX:NAN) share price a buy? appeared first on Motley Fool Australia. –

questioning whether westpac share price is a buy represented by man in red shirt scratching his head

The Nanosonics Ltd (ASX: NAN) share price is currently trading approximately 25% lower than its 52-week high.

Is this a buying opportunity for investors? I thought I would take a closer look to find out:

The good.

Nanosonics’ trophon EPR product is a best in class disinfection system for ultrasound probes. Over the last few years, the company has been growing its installed base at a consistently strong rate.

So much so, at the end of FY 2020 it had grown its installed base by 13% over the 12 months to 23,720 units. This is positive for two reasons. The first is the revenue it generates from unit sales, the second is the sales it then generates from the consumables it requires.

This means that as its installed base grows, so too do the recurring revenues from consumables. For example, full year consumables and service revenue was up 36% to $70.1 million in FY 2020. This now accounts for approximately 70% of its total revenue.

Another reason to be positive is the increased awareness of infection prevention because of the pandemic.

Management commented: “The COVID-19 pandemic has reinforced the importance of infection prevention and given increased prominence to this important topic, not just amongst the medical community but in all communities. The Company considers that this can only be positive for the longer term fundamentals of the business.”

The bad.

For several years now, Nanosonics has been promising to release new products targeting other unmet needs with similar addressable markets.

Given its great reputation, distribution channels, and expertise, the market has been very excited about these new products and have been using them to justify the premium its shares trade at. At present, Nanosonics’ shares are changing hands for 127x FY 2019 (pre-COVID) earnings.

However, these new products just keep getting pushed further and further back.

After first promising a new product back in FY 2017, according to Goldman Sachs, the latest estimate is now FY 2022.

Management explained: “Commercialisation of the new technology is no longer expected to be in FY21 but will likely be in FY22, with the ultimate launch timing continuing to be dependent on the necessary technical milestones being met as well as the timing of individual market regulatory approvals.”

My concern is that if the market starts to doubt this latest estimate, it could begin to take these products out of the equation, causing a significant de-rating of its shares.

The verdict.

While the delays are disappointing, I think it could still be worth buying and holding Nanosonics’ shares for the long term.

However, due to the premium its shares trade at and management’s habit of missing deadlines, I would suggest investors restrict an investment to just a small part of a balanced portfolio.

After which, when things become more certain, investors could consider increasing their holding.

Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

Find out the names of our 3 Post COVID Stocks – For FREE!

*Returns as of 6/8/2020

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nanosonics Limited. The Motley Fool Australia has recommended Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Is the Nanosonics (ASX:NAN) share price a buy? appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!